Product Code: ETC063825 | Publication Date: Jun 2023 | Updated Date: Jan 2024 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
The Malaysia Barbiturate Drugs market is estimated to grow at a CAGR of 17.8% during the forecast period 2021-2027. The Malaysia Government has implemented several measures like providing incentives, tax benefits and financial support for R&D activities and imports in order to encourage local manufacturing of drugs and medical equipment. This has enabled the players in the barbiturate drugs market to increase their production capacity as well as expand their product portfolio. Furthermore, there are various initiatives taken by the government such as increasing public healthcare expenditure, introducing policies that promote generic drug consumption, enhancing overall awareness about health conditions among citizens etc., which have further fuelled growth in this sector. Moreover, rising prevalence of certain diseases like epilepsy & sedative hypnotic indication across Malaysia is expected to drive growth in this market over the coming years
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Malaysia Barbiturate Drugs Market Overview |
3.1 Malaysia Country Macro Economic Indicators |
3.2 Malaysia Barbiturate Drugs Market Revenues & Volume, 2020 & 2027F |
3.3 Malaysia Barbiturate Drugs Market - Industry Life Cycle |
3.4 Malaysia Barbiturate Drugs Market - Porter's Five Forces |
3.5 Malaysia Barbiturate Drugs Market Revenues & Volume Share, By Types, 2020 & 2027F |
3.6 Malaysia Barbiturate Drugs Market Revenues & Volume Share, By Application, 2020 & 2027F |
4 Malaysia Barbiturate Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Malaysia Barbiturate Drugs Market Trends |
6 Malaysia Barbiturate Drugs Market, By Types |
6.1 Malaysia Barbiturate Drugs Market, By Types |
6.1.1 Overview and Analysis |
6.1.2 Malaysia Barbiturate Drugs Market Revenues & Volume, By Types, 2018 - 2027F |
6.1.3 Malaysia Barbiturate Drugs Market Revenues & Volume, By Ultra-Short Acting Barbiturate, 2018 - 2027F |
6.1.4 Malaysia Barbiturate Drugs Market Revenues & Volume, By Short-Acting Barbiturate, 2018 - 2027F |
6.1.5 Malaysia Barbiturate Drugs Market Revenues & Volume, By Long-Acting Barbiturate, 2018 - 2027F |
6.1.6 Malaysia Barbiturate Drugs Market Revenues & Volume, By Combination Drugs, 2018 - 2027F |
6.2 Malaysia Barbiturate Drugs Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Malaysia Barbiturate Drugs Market Revenues & Volume, By Hospital Pharmacies, 2018 - 2027F |
6.2.3 Malaysia Barbiturate Drugs Market Revenues & Volume, By Retail Pharmacies, 2018 - 2027F |
6.2.4 Malaysia Barbiturate Drugs Market Revenues & Volume, By Online Pharmacies, 2018 - 2027F |
7 Malaysia Barbiturate Drugs Market Import-Export Trade Statistics |
7.1 Malaysia Barbiturate Drugs Market Export to Major Countries |
7.2 Malaysia Barbiturate Drugs Market Imports from Major Countries |
8 Malaysia Barbiturate Drugs Market Key Performance Indicators |
9 Malaysia Barbiturate Drugs Market - Opportunity Assessment |
9.1 Malaysia Barbiturate Drugs Market Opportunity Assessment, By Types, 2020 & 2027F |
9.2 Malaysia Barbiturate Drugs Market Opportunity Assessment, By Application, 2020 & 2027F |
10 Malaysia Barbiturate Drugs Market - Competitive Landscape |
10.1 Malaysia Barbiturate Drugs Market Revenue Share, By Companies, 2020 |
10.2 Malaysia Barbiturate Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |